XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue:    
Premiums and policy fees $ 9,080,039 $ 9,256,945
Ceded reinsurance premiums and policy fees (2,680,050) (2,725,303)
Net investment income 9,050,325 9,528,948
Other income 412,982 343,467
Revenue before net investment gains (losses) 15,863,296 16,404,057
Net investment gains (losses):    
Other-than-temporary impairments (393,455) 0
Other realized investment gains, net 6,021,653 4,645,699
Change in fair value of equity securities 14,121,883 6,208,148
Total net investment gains 19,750,081 10,853,847
Total revenues 35,613,377 27,257,904
Benefits, claims and settlement expenses:    
Life 17,137,166 17,265,646
Ceded reinsurance benefits and claims (2,380,366) (2,399,361)
Annuity 993,937 1,015,308
Dividends to policyholders 324,543 333,331
Commissions (121,287) (129,835)
Amortization of cost of insurance acquired 714,970 744,850
Operating expenses 7,115,530 7,870,909
Interest expense 4,051 0
Total benefits and other expenses 23,788,544 24,700,848
Income before income taxes 11,824,833 2,557,056
Income tax expense 2,069,673 340,494
Net income 9,755,160 2,216,562
Net income attributable to noncontrolling interests (92,097) (127,956)
Net income attributable to common shareholders $ 9,663,063 $ 2,088,606
Amounts attributable to common shareholders    
Basic income per share (in dollars per share) $ 3.05 $ 0.65
Diluted income per share (in dollars per share) $ 3.05 $ 0.65
Basic weighted average shares outstanding (in shares) 3,171,919 3,233,773
Diluted weighted average shares outstanding (in shares) 3,171,919 3,233,773